Davidov, Michael
June 1976
Angiology;Jun1976, Vol. 27 Issue 6, p347
Academic Journal
The development of modern pharmacologic diuretic agents has revolutionized the therapy of arterial hypertension. The diuretics currently available are easily administered orally, are effective in the presence of alkalosis or acidosis, are non-toxic and have a low incidence of side effects which are readily circumvented or treated. Loop diuretics such as furosemide have the capacity to be effective in patients with diminished renal function or clinical situations that have a powerful stimulus to sodium retention. In clinical circumstances when renal potassium loss is to be prevented such as in patients receiving digitalis, the addition of a potassium-sparing diuretic to either a thiazide or furosemide will achieve the clinical goal of providing an effective diuresis while inhibiting potassium excretion. The mechanism of antihypertensive activity of the diuretic agents appears to be the reduction of extracellular fluid volumes and plasma volumes. Hence, the clinical dictum that to be effective as an antihypertensive agent, diuretics should be administered in diuretic doses. Besides being the cornerstone of initial antihypertensive therapy, diuretics also play an important role in antihypertensive therapy of patients with moderate to severe hypertension who are receiving potent antihypertensive drugs of the vasodilator or sympatholytic class of compounds. Indeed, one of the most important steps in the successful therapy of these patients receiving multiple drugs, is the re-assessment of the diuretic agent (Figure 5). The sodium retention and consequent fluid volume expansion associated with the administration of these potent antihypertensive agents may often cause these patients to develop apparent drug resistance since the thiazide diuretics are not potent enough to counteract the powerful stimulus to sodium retention caused by these antihypertensive agents. The re-evaluation of the diuretic agent at this point will usually necessitate the substitution of furosemide for thiazide or the doubling of the dose of the present loop diuretic. A working knowledge of the physiology of urine formation and the sites of action of currently available diuretic agents (Figure 1) will enable the clinician to tailor the diuretic agent to the clinical circumstances of an individual patient and allow the clinician to rationally select a diuretic for the treatment of arterial hypertension.


Related Articles

  • THE PROBLEM OF THE MODERATE TO SEVERE HYPERTENSIVE PATIENT. Finnerty Jr., Frank A. // Angiology;Jun1976, Vol. 27 Issue 6, p333 

    Evaluates the relationship of volume expansion to antihypertensive drug refractoriness and the long-term effects of short term reduction of arterial pressure with maintenance of urinary output in patients with refractory hypertension. Decrease in arterial pressure during drug-induced diuresis as...

  • Antihypertensive and Some Biochemical Effects of Hydrochlorothiazide and Furosemide in Some Nigerians. Iyalomhe, G. B. S.; Omogbai, E. K. I.; Ozolua, R. I. // Journal of Medical Sciences;2007, Vol. 7 Issue 6, p977 

    The objective of this prospective, randomised, open, single-centre study was, therefore, to determine the antihypertensive and biochemical effects of 25 mg oral hydrochlorothiazide and 40 mg oral furosemide given once daily for 21 days to 40 patients with mild to moderate uncomplicated essential...

  • When to review antihypertensives. Jackson, Graham; Ferro, Albert // Update;3/18/2004, Vol. 68 Issue 5, p243 

    A single antihypertensive drug is often not enough to control hypertension when treating to target 140/85 mmHg or less for patients with uncomplicated hypertension and 130/80 mmHg or less in patients with diabetes or other high-risk hypertensives and those with renal disease. However,...

  • LONG TERM FOLLOW-UP OF AGGRESSIVE MEDICAL THERAPY OF ACCELERATED HYPERTENSION WITH AZOTEMIA. Davidov, Michael; Mroczek, William; Gavrilovich, Lillian; Finnerty Jr., Frank // Angiology;May1975, Vol. 26 Issue 5, p396 

    Details the long-term follow-up of aggressive medical therapy of accelerated hypertension with azotemia. Control of arterial blood pressure following intravenous administration of diazoxide and furosemide to patients; Observation of significant improvement in renal function; Efficacy of...

  • Antihypertensives.  // Cardiovascular Pharmacology Manual;2008, p11 

    The article presents information about several antihypertensives, they include mannitol, bumentanide and furosemide. Some of the diseases treated by these antihypertensives are hypertension and edema. Their adverse effects include hyponatremia, metabolic alkalosis, dehydration, dizziness and...

  • Augmented antihypertensive effect of a fixed combination formula of candesartan and hydrochlorothiazide combined with furosemide in a patient on peritoneal dialysis. Kuriyama, Satoru; Otsuka, Yasushi; Ueda, Hiroyuki; Sugano, Naoki; Yoshizawa, Takeo; Yamada, Taku; Hosoya, Tatsuo // Clinical & Experimental Nephrology;Feb2011, Vol. 15 Issue 1, p175 

    38-year-old female patient on peritoneal dialysis (PD) due to type 1 diabetic nephropathy with a well-preserved residual renal function did not respond well to the conventional antihypertensive therapy consisting of candesartan, furosemide, and bunazosin. Switching candesartan for a fixed...

  • When Thiazides are Associated with Hyponatremia.  // Primary Care Reports;Jun2012 Clinical Briefs, p1 

    The article reports a study by D Rastogi and colleagues, which shows the association of coadministration of an angiotensin-converting enzyme (ACE) inhibitor and concomitant hypokalemia, as the only significant risk factor for hyponatremic hospital admission with thiazide diuretic, apart from age.

  • A snapshot of antihypertensive use in Nigeria.  // PharmacoEconomics & Outcomes News;2/12/2005, Issue 471, p12 

    Discusses research being done on the utilization of antihypertensive drugs and diuretics among patients with hypertension in Nigeria. Reference to a study by K. B. Yusuff and colleagues, published in the January 2005 issue of "Pharmacoepidemiology and Drug Safety"; Percentage of patients with...

  • Important effect of treatment of severe and malignant essential hypertension. GaĊĦanin, Isma // Kardio List;Mar/Apr2012, Vol. 7 Issue 3/4, p132 

    Background As a primary care physician I recorded that the administration of antihypertensive drugs did not result in the expected therapeutic effect in a certain number of patients suffering from essential hypertension (EH). The aim of this paper is to show, based on the significant effect of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics